In this video series, presented in April of 2020, GRACE Faculty and Members of the Board of Directors have a candid discussion regarding cancer and...
In April of 2020, GRACE Board Members Dr. H. Jack West, Dr. Jared Weiss and Dr. Ben Levy had a candid discussion regarding telemedicine in the time of...
Narjust Duma, MD, Assistant Professor and Thoracic Oncologist at the University of Wisconsin Carbone Cancer Center discusses COVID 19 and how it...
Narjust Duma, MD, Assistant Professor and Thoracic Oncologist at the University of Wisconsin Carbone Cancer Center interviews Juanita Segura, lung...
GRACE is very happy to bring to you more videos from our program, Supportive Care in Cancer Treatment. In this video our host, Dr. Arjun Gupta speaks...
Join us for the 2025 Gathering of Friends of GRACE! RSVP now! RSVP Online Here
GRACE is pleased to introduce three amazing individuals participating in the 2024-25 GRACE Clinical Trials Experiences Storytelling Program We are...
GRACE is pleased to introduce three amazing individuals participating in the 2024-25 GRACE Clinical Trials Experiences Storytelling Program We are...
GRACE is pleased to introduce three amazing individuals participating in the 2024-25 GRACE Clinical Trials Experiences Storytelling Program We are...
Hi, my spouse has been taking Tarceva for a few years. To my knowledge, generic Tarceva has been available on market since last year. I was wondering if any of you know the efficacy of the generic Tarceva. Those generics include Mylan, Teva and Armas. Do they have the same efficacy as the branded Tarceva? Do these generic brands show differences in efficacy from one to another? Any information is appreiated? Thank you.
JT
GRACE is excited to have again partnered with Clinical Care Options to develop an Interactive Decision Support Tool and downloadable resource to help you understand more about your disease and treatment options, so you can become partners with your oncology team in your cancer care.
As many of you know, the costs of treating a new disease or virus are often astronomical, and most insurance companies are in flux as they incorporate these therapies into their step therapies and tier programs, and work to come up with medical necessity criteria to allow coverage for experimental treatments.
Opinion and/or Advice Needed Please....
In this time of social distancing and limiting clinic exposure, the sudden need for telemedicine and web consults is perhaps changing the future of medicine on a faster pace than we have previously thought possible.
In this three part series the doctors discuss a wide range of topics surrounding the use of telemedicine and potential challenges for providers and patients alike.
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.